Subepithelial B cells in the human palatine tonsil .2. Functional characterization

被引:30
作者
Dono, M
Zupo, S
Augliera, A
Burgio, VL
Massara, R
Melagrana, A
Costa, M
Grossi, CE
Chiorazzi, N
Ferrarini, M
机构
[1] UNIV ROMA LA SAPIENZA,IST CLIN MED GEN & TERAPIA MED 1A,ROME,ITALY
[2] IST GIANNINA GASLINI,DIV ORL,I-16148 GENOA,ITALY
[3] OSPED SAN MARTINO GENOVA,SERV AUTONOMO FISIOPATOL RIPROD,GENOA,ITALY
[4] UNIV GENOA,IST ANAT UMANA NORMALE,GENOA,ITALY
[5] IST NAZL RIC CANC,SERV PATOL CLIN,I-16132 GENOA,ITALY
[6] N SHORE UNIV HOSP,DEPT MED,MANHASSET,NY
[7] CORNELL UNIV,COLL MED,MANHASSET,NY
[8] UNIV GENOA,DIPARTIMENTO ONCOL CLIN & SPERIMENTALE,GENOA,ITALY
关键词
extrafollicular; subepithelial B cell; palatine tonsil; T-independent antigen;
D O I
10.1002/eji.1830260912
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study investigates the main functional features of subepithelial (SE) B cells and compares them with those of purified germinal center (GC) and follicular mantle (FM)B cells isolated from the same tonsils. Unlike FM B cells, SE B cells failed to produce polyspecific antibodies in vitro; unlike GC B cells, SE B cells expressed high levels of Bcl-2 and failed to undergo spontaneous apoptosis in vitro. The most striking function of SE B cells was their ability to produce IgM antibodies to T cell-independent type-2 (TI-2) (but not to TI-1) antigens (Ag). These antibodies could not be detected when both FM and GC B cells were stimulated with TI-2 Ag in vitro. Moreover, B cells isolated from peripheral blood were unable to mount a response to TI-2 Ag. The latter finding is consistent with the observation that B cells with the phenotypic features of SE B cells were virtually absent in the peripheral blood and emphasizes the notion that SE B cells belong to a subset of non-recirculating B cells. SE B cells were by far superior to FM B cells in mixed lymphocyte reaction (MLR) stimulation of allogeneic T cells in vitro, although they were not as efficient as dendritic cells (DC). In order to stimulate T cells efficiently, SE B cells had to be exposed to anti-mu antibody, a treatment which induced expression of activation markers such as CD80, CD86, CD69 and CD39, usually absent in resting SE B cells. CD80 and CD86 molecules expressed by SE B cells participated in the chain of events required to promote the proliferation of allogeneic T cells as demonstrated by inhibition tests with the appropriate mAb. The expression of CD80 and CD86 by anti-mu-treated SE B cells was not, however, the sole explanation for their good antigen presenting capacities since the exposure of FM B cells to anti-mu antibody also induced expression of these surface structures. Nevertheless, these cells failed to become good MLR stimulators. Collectively, the above data contribute further to the characterization of a distinct subset of tonsillar B cells which resemble, both phenotypically and functionally, the B cells of the splenic marginal zone.
引用
收藏
页码:2043 / 2049
页数:7
相关论文
共 39 条
[21]  
MOLLER P, 1989, LEUCOCYTE TYPING, V4, P213
[22]  
MOLLER P, 1989, LEUCOCYTE TYPING, V4, P222
[23]  
MOND JJ, 1983, J IMMUNOL, V131, P633
[24]   HUMAN TONSIL INTRAEPITHELIAL B-CELLS - A MARGINAL ZONE-RELATED SUBPOPULATION [J].
MORENTE, M ;
PIRIS, MA ;
ORRADRE, JL ;
RIVAS, C ;
VILLUENDAS, R .
JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (08) :668-672
[25]   THYMUS-INDEPENDENT ANTIGENS - COMPLEXITY OF LYMPHOCYTE-B ACTIVATION REVEALED [J].
MOSIER, DE ;
SUBBARAO, B .
IMMUNOLOGY TODAY, 1982, 3 (08) :217-222
[26]  
MOSIER DE, 1977, J IMMUNOL, V119, P1874
[27]   Efficient Presentation of Soluble Antigen by Cultured Human Dendritic Cells Is Maintained by Granulocyte/Macrophage Colony-stimulating Factor Plus Interleukin 4 and Downregulated by Tumor Necrosis Factor α [J].
Sallusto, Federica ;
Lanzavecchia, Antonio .
JOURNAL OF IMMUNOLOGY, 2018, 200 (03) :887-896
[28]   CBA/N IMMUNE DEFECTIVE MICE - EVIDENCE FOR THE FAILURE OF A B-CELL SUB-POPULATION TO BE EXPRESSED [J].
SCHER, I .
IMMUNOLOGICAL REVIEWS, 1982, 64 :117-136
[29]  
SNAPPER CM, 1993, J IMMUNOL, V150, P2737
[30]  
SPENCER J, 1985, CLIN EXP IMMUNOL, V62, P607